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Grant Morahan3 and Jacqueline K Phillips2*†Abstract
Background: Nephronophthisis (NPHP) as a cause of cystic kidney disease is the most common genetic cause of
progressive renal failure in children and young adults. NPHP is characterized by abnormal and/or loss of function of
proteins associated with primary cilia. Previously, we characterized an autosomal recessive phenotype of cystic
kidney disease in the Lewis Polycystic Kidney (LPK) rat.
Results: In this study, quantitative trait locus analysis was used to define a ~1.6Mbp region on rat chromosome
10q25 harbouring the lpk mutation. Targeted genome capture and next-generation sequencing of this region
identified a non-synonymous mutation R650C in the NIMA (never in mitosis gene a)- related kinase 8 (Nek8) gene.
This is a novel Nek8 mutation that occurs within the regulator of chromosome condensation 1 (RCC1)-like region of
the protein. Specifically, the R650C substitution is located within a G[QRC]LG repeat motif of the predicted seven
bladed beta-propeller structure of the RCC1 domain. The rat Nek8 gene is located in a region syntenic to portions
of human chromosome 17 and mouse 11. Scanning electron microscopy confirmed abnormally long cilia on LPK
kidney epithelial cells, and fluorescence immunohistochemistry for Nek8 protein revealed altered cilia localisation.
Conclusions: When assessed relative to other Nek8 NPHP mutations, our results indicate the whole propeller
structure of the RCC1 domain is important, as the different mutations cause comparable phenotypes. This study
establishes the LPK rat as a novel model system for NPHP and further consolidates the link between cystic kidney
disease and cilia proteins.
Keywords: Cilia, Directed next generation sequencing, Electron microscopy, Genome capture,
Immunohistochemistry, Nek8, NPHP, Polycystic kidney diseaseBackground
Cystic kidney diseases are amongst the most common
monogenetic disorders in the human population, affect-
ing up to 1 in 400 individuals [1,2]. Numerous studies
have been carried out in humans, zebrafish and rodents
[3,4] indicating the important function that cilia and
associated proteins play in the pathogenesis of renal cys-
tic diseases [5], including polycystic kidney disease
(PKD) [6,7] and nephronophthisis (NPHP) [8] incorpor-
ating Merkel Gruber and Joubert Syndromes [9].* Correspondence: jacqueline.phillips@mq.edu.au
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reproduction in any medium, provided the orIn addition to progressing our understanding of cystic
pathophysiology, rodent models of cystic kidney disease
have played a major role in facilitating the molecular
characterization of novel genes required for normal
renal epithelial cell function [10,11] and establishing the
importance of the ciliary-centrosome interactions in
coordinating many aspects of cell division [12]. The
available evidence suggests that defects in cilia or centro-
somes can have profound effects on the control of cell
division. For example, mutation of the Pkhd1 gene en-
coding for fibrocystin/polyductin results in autosomal
recessive (AR) PKD. This gene was first identified in the
PCK rat [13] and encodes an integral structural compo-
nent of both the cilia and basal body associated with theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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polycystin-1 and -2 expression, both of which have been
shown to regulate the JAK-Stat pathway, which in turn
controls cell cycle arrest in G0 and G1 [16]. When either
protein is defective, as occurs in human autosomal dom-
inant (AD) PKD, unregulated cell growth can occur
[15,17]. Other key pathways engaged in cellular pro-
cesses, such as cell cycle regulation, growth and apop-
tosis, that are regulated by polycystin-1 include those
involving Wnt signaling [15]. Wnt signaling has been
shown to have oncogenic activity, becoming deregulated
in certain types of cancers [18,19] and polycystin-1 regu-
lates genes responsive to Wnt signaling [20], inhibiting
proliferation and maintaining normal microtubular
structures.
The NPHP gene family (NPHP1 through to NPHP12)
encodes a group of proteins that are expressed in the
primary cilium, basal bodies/centrosomes or mitotic
spindles, and are critical to cell division and cilia func-
tion [8,21]. For example Inversin (NPHP2) is thought to
act as a molecular switch between the different Wnt sig-
naling pathways and is associated with the accumulation
of proteins within the cilia [22,23]. NPHP1 encodes for
nephrocystin-1, and has been localised to centrosomes
in interphase and the mitotic spindle pole during mitosis
[24], while NPHP9, encoding for NIMA (never in mi-
tosis gene a)- related kinase 8 (Nek8), localises to the
proximal region of the primary cilium and is proposed
to modulate ciliary targeting of polycystin-1 and
polycystin-2 [25,26].
The Lewis Polycystic Kidney (LPK) rat is a spontan-
eous rat model of ARPKD that has been phenotypically
characterized [27-29]. The phenotype is localized to the
kidney, which presents with large renal cysts. The LPK
rat contrasts with the PKD/Mhm cystic rat model, which
has a mutation in the Pkdr1 gene (encoding the protein
SamCystin), and which presents additionally with liverFigure 1 Localization of the lpk locus within chromosome 10. A. Posit
chromosome 10 (shown in centiMorgan, cM) locations as analysed on the
cystic phenotype. B. Sample gel for marker D10Mgh14 showing samples sc
heterozygote (H).cysts [30]. Renal cyst formation in the early stages of dis-
ease in the LPK model is confined to the collecting
ducts, comparable to human ARPKD, and the animals
present with a concurrent and marked hypertensive
phenotype [28]. To fully appreciate the pathological
basis of progression of the polycystic kidney phenotype
in this model, we sought to identify the gene mutated in
the LPK rat and its predicted impact on protein function
using a positional cloning approach. Further analysis fo-
cused on conserved elements within the mutated protein
to predict structure and function.
Our results determined that the mutation responsible
for the rat LPK model is a non-synonymous mutation
R650C in the Nek8 gene, in a region syntenic to portions
of human chromosome (chr) 17 and mouse chr 11. This
is a novel Nek8 mutation that occurs within the regula-
tor of chromosome condensation 1 (RCC1)-like region
of the protein and is located within a G[QRC]LG) motif
that we predict is important for the structural organisa-
tion of seven bladed beta-propeller RCC1 like proteins.
Scanning electron microscopy confirmed abnormal renal
cilia in the LPK and fluorescence immunohistochemistry
revealed altered cilia localisation of the Nek8 protein.
Results
Genetic analysis locates the lpk QTL on rat chromosome
10q25
Backcross (BC1) progeny were produced and character-
ized. The genetic map obtained from MapManager [31]
analysis of 139 BC1 progeny is shown in Figure 1A. The
characteristic LPK phenotype, namely cyst to kidney
ratio, was located within the map using WinCart Qtl.
The output from WinCart Qtl for marker-trait linkage is
shown in Figure 2. The cyst/kidney area ratio quantita-
tive trait locus (QTL) (LPK phenotype) mapped the lpk
locus with a logarithm of odds (LOD) score of 50 to the
region defined by the markers D10Rat30 (at 63.75Mbpion of the lpk locus (red) relative to polymorphic markers on
backcross 1 (BC1) generation, scoring the presence or absence of renal
ored as homozygote LPK (B), homozygote Wistar Kyoto (A) or
Figure 2 Locating the lpk QTL. Quantitative trait loci for PKD phenotypic markers were determined using WinCart QTL [67]. The markers used
for analysis are shown along the x-axis (red triangles) and span 86cM from D10Rat43 to D10Rat12. On the y axis, the evidence for linkage is
recorded as a logarithm of odds (LOD) score. The QTL illustrated is the cyst to kidney area ratio. The QTL was determined using Composite
interval mapping with model 6 (standard model) with a window size of 0.5 cM and walk speed of 1cM a forward and backward regression. A
threshold of 7.5 (LR) and 1.6 (LOD – black hashed line) was determined by permutations.
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tions were taken from the RGSC genome ver3.4 [32].
Characterization of an independent mapping population,
a second filial (F2) generation of 152 progeny, confirmed
the location of the lpk locus but was unable to provide any
greater resolution with the peak region of linkage located
between D10Rat30 and D10Rat161 (at 67.09Mbp).
Comparative genomics identifies candidate genes
Localization of the lpk mutation on rat chromosome 10
(RRA10) allowed comparison with syntenic regions of
mouse and human chromosomes, MMU11 and HSA 17
respectively (Figure 3). The region of interest as defined
by the QTL analysis (63.6 to 65.2 on RRA10; Figure 3C),
projected onto HSA17 27.6Mbp to 25.8Mbp (Figure 3A)
and MMU11 77.5Mbp to 77.8Mbp (Figure 3B), based on
shared molecular markers. Within this region we identi-
fied 46 syntenic genes. Two of these genes have previously
shown to be associated with cystic kidney disease in mam-
mals, namely, the genes coding for the Nek8 protein and
for the intraflagellar transport protein 20 (IFT20).
Following this comparative analysis, several approaches
were explored to identify additional genes in the QTL
defined region that may be causal for the LPK phenotype.
An initial subset of genes was determined by review of all
genes in the region, captured using Ensembl Biomart
[33] based on qualitative assessment criteria linked to
known function and network pathways. Analyses indi-
cated 13 genes, in addition to Nek8 and Ift20 within this
area that could potentially result in cystic kidney disease,namely: RGD1309077, Phf12, Flot2, Spag5, Sdf2, Supt6h,
Proca1, Traf4, Sarm1, Nlk and Ksr1 (Additional file 1:
Table S1). These candidate genes span approximately 478
kbp of genomic sequence so a genome capture array was
employed to sequence the entire lpk locus (~1.6Mbp) ra-
ther than using gene-by-gene sequencing.
Targeted genome next-generation sequencing of the
lpk region
Nimblegen arrays were used for exon capture and se-
quencing of genomic DNA spanning the markers
D10Rat238 and D10Rat161 on RRA10 (4,406,155 bp).
Totals of 44 million reads and 48 million reads were
generated for the LPK sample and control Lewis (LEW/
SsNArc) DNA, respectively. 76% of the reads mapped to
the target region with an average depth coverage of 500.
Reads were aligned to the rn4 rat assembly to identify
single nucleotide polymorphisms (SNPs) within exons.
Only one single homozygous and 3 heterozygous SNPs
(Table 1) were found unique to the LPK strain. The
homozygous mutation was located at 64,469,050 bp
(chr10) within exon 14 of the Nek8 gene, consisting of a
base change of cytosine to thymine. This corresponded
to position 2008 within the cDNA and would cause an
arginine to cysteine change at position 650 in the pro-
tein product. Conservation analysis identified the rele-
vant amino acid (arginine) to be conserved in published
Nek8 mRNA sequences [34]. The non-synonymous het-
erozygous SNPs identified in the sequence analysis were
in two separate genes. The first was a het-2 mutation
Figure 3 Human, mouse and rat synteny. Map of the syntenic relationship between human (A), mouse (B) and rat (C) over the region defined
in this study, as generated by VCMap [32] illustrating the annotated genes. A: Homo sapiens: NCBI 37.2, B: Mus muscuus: NCBI 37.1, C: Rattus
norvegicus: NCBI 4.2. Genes of particular interest to this study are highlighted.
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Fam101b (family with sequence similarity 101) of A/G
(P176L) with a coverage of 654 reads. The second gene
contained two low frequency het-1 mutations of T/A
(57/152 reads) and A/T (60/155 reads) at location
66106990 bp and 66106990 bp within the krt1-18 (Kera-
tin, type 1 cytoskeletal 18) gene. Conservation analysis
of all three heterozygous SNPs (using Rattus norvegicus,
Mus musculus, Homo sapiens, Canis lupis, Gallus gallus
and Xenopus tropicalis) indicated that although the nu-
cleotide in which the SNP occurred was conserved
across species, the actual codons were not conserved.
These SNPs were not considered further.Confirmation of the mutation in the Nek8 gene
Four BC1 animals – two affected and two unaffected as
defined by kidney histology and genotyping - were ana-
lysed in more detail. The parental lines of Brown Norway
(BN), Wistar Kyoto (WKY) and the LPK mutant were also
analyzed. Sequencing of BN and WKY DNA revealed a
homozygous nucleotide [C] at location 64,469,050 bp
(chr10) (Figure 4). The BC1 animals that were cystic nega-
tive were either homozygous for nucleotide [C] or were
heterozygous [C/T]. The animals positive for cysts were
homozygous for [T], as was the LPK mutant. These results
confirmed the data obtained from the targeted genome
sequencing.
Figure 4 Sequencing of LPK Nek8 mutation. Chromographs show the lpk mutation as a SNP within the Nek8 gene. Lines A and B are the
Brown Norway (BN) reference sequence (REF) (NC_005109.2, gene ID: 287473) and the BN parent sequence data; both showed a homozygous
Cytosine (C) at the position of the SNP (red box). Lines C and D are the LPK parent and BC1 (1: cystic positive) progeny and contained the
homozygous Thymidine (T). Panel E is the BC1 (0: cystic negative) progeny and is heterozygous (C/T). Panel F is the other parental rat strain
Wistar Kyoto (WKY) which had a homozygous Cytosine (C) at the position of the SNP.
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The location of R650C within the Nek8 protein is shown
in Figure 5. Alignment of the Nek8 protein sequence
across 7 species indicated a high level of conserved resi-
dues within the N-terminal serine/threonine kinase re-
gion of the protein as compared to the C-terminal RCC1
domain (Figure 5A). The R650C located to a conserved
RCC1 like repeat domain containing the repeated motif
G[QRC]LG (Figure 5B). The predicted ancestral DNA
sequence with evolutionary conserved amino acids in
the Nek8 protein is shown in Additional file 2: Figure
S1, and suggests that R650C mutation is located within
an evolutionary conserved domain.
The overall structure of the Nek8 protein was subse-
quently interpreted using the extensively studied RCC1-
like domains in proteins [35,36] as a model. Homology
alignment using Phyre2 [37] and ESyPred [38] showed
that the serine/threonine kinase at the N terminal of the
Nek8 protein had up to 40% homology to over 100 dif-
ferent kinases (data not shown). The RCC1 domain in
the C terminal half of the protein aligned with three pro-
teins, PRP20P and RCC1/BLIP and Herc2, which were
subsequently used to predict the tertiary structure of the
Nek8 protein. The Nek8 RCC1 domain comprised of 6
identifiable RCC1-like repeat domains (Additional file 3:
Figure S2). An additional RCC1-like repeat domain was
annotated as a non-canonical domain as it did not con-
tain the typical repeat motif. The 3D structure shown in
Figure 6 provides a model for the serine/threonine kin-
ase and the RCC1 domains of Nek8.
A manual comparison of the predicted 3D structure of
Nek8’s RCC1 domain to the Mesocricetus auratus(Golden hamster) [39] confirmed that repeat regions
within the RCC1 domain formed the blades of a classical
propeller structure [36,40]. The R650C mutation in the
LPK Nek8 protein is located in blade 7 (Figure 6C).
Relative occurrence of G[QRC]LG within proteins
The R650C mutation is within the core G[QRC]LG
motif that was also noted within the hamster RCC1 pro-
tein. To investigate the occurrence of this motif and pos-
sible protein function, the Expasy ScanProsite tool [41]
was used to scan for the sequence within UniProtKB/
Swiss-Prot databases. The original search using the G
[QRC]LG motif within the homo sapiens taxa yielded
966 proteins. The final sequence search was refined to
contain the two conserved Glycine residues upstream
from the motif of interest. The final search motif
was GX(5)GX(4)G[QRC]LG. This search identified 23
proteins: DACT3, FBX24, GLI1, HERC1, HERC2,
HERC3, HERC4, HERC5, HERC6, IBTK, MYCB2, Nek8,
Nek9, PTF1A, RCBT1, RCBT2, RCC1, RCC2, RCCD1,
RPGR, SRGEF, WBS16, WDFY4. Of the 23 identified
proteins, five [SGREF, RPGR, RCC2, RCC1, and RCBT2]
were characterized as guanine releasing factors, DACT3
and GLI1 are involved in the Hedgehog and Wnt signal-
ing pathways, 8 proteins were associated with the
ubiquitin pathway [Herc1 to 6, FBX24, MYCBP2], 5 pro-
teins were linked to cell cycle regulation [Nek8, Nek9,
RCBT1, RCC1 and RCC2], while little is known about
WBS16, WDFY and RCCD1. The majority of the proteins
(18/23) contained multiple copies of the RCC1 repeats and
are expected to form toroid 3D structures important for
protein-protein interactions.
Table 1 Non-synonymous mutations
Position* Ref Obs A C G T total used SNP Type Gene ID
(ENSRNOG)
Name Description cDNA Prot AA
change
63385139 G AG 339 1 314 0 714 654 het2 00000006674 Fam101b Protein FAM101B 647 176 P- > L
64469050 C T 0 0 0 392 393 392 hom 00000012866 Nek8 serine/threonine-protein
kinase Nek8
2008 650 R- > C
66106990 T TA 25 0 0 32 152 57 het1 00000022699 LOC303341 Keratin, type I cytoskeletal 18 464 155 Y- > F
66106991 A AT 32 0 0 28 155 60 het1 00000022699 LOC303342 Keratin, type I cytoskeletal 19 463 155 Y- >N
List of non-synonymous mutations derived from Nimblegen array target sequencing and bounded by the genes Myo1c and Slc6a4 and using the flanking markers D10Rat161 and D10Rat238 [62685555-67091740].
*Position location in base pairs (bp) was determined using the Rat Genome Browser Gateway using the Baylor 3.4/ build rn4 (http://genome.ucsc.edu/cgi-bin/hgGateway?org=rat). Ref: nucleotide on the ref sequence.
Obs: nucleotide recorded from transcripts. A C G T: number of transcripts recorded with a change to the reference. Total: total number of transcripts recorded with a change to the reference. Used: reads that support
the change after consideration of read quality. SNP type: defines type of mutation. DNA: position of the base change within the cDNA. prot: position of the amino acid change within the protein. AA change: resultant
change of amino acid in the protein. Hom: homozygous. Het: heterozygous.
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Figure 5 Location of Nek8 mutation and species sequence alignment. Sequence alignment of Nek8 protein from 7 representative species,
created from known Nek8 mRNA sequences with the MAFFT algorithm [77]. Panel A illustrates the complete Nek8 alignment. Black indicates
100% conservation scaled to white (0% conservation). The location of the R650C mutation is highlighted within the red box. The serine/threonine
kinase region (N terminal) shows high conservation while the alpha tubulin suppressor domain region of the protein (C terminal) shows less
conservation and contains the regulator of chromosome condensation-1 (RCC1) domains. Panel B shows the area of the R650C mutation in
greater detail to illustrate the conservation of the G[R]LG across the species. The R650C lies within a RCC1 domain. Species represented are the
Rattus (rat), Danio (zebra fish), Gallus Gallus (rooster), Xenopus (frog), Homo (human), Mus muscularis (mouse) and Saccoglossus (acorn worm)
and their respective accession numbers.
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epithelial cells
Under scanning electron microscopy, control Lewis rat
kidneys had normal morphology, with cilia present on
the majority of cells (excluding intercalated cells of col-
lecting tubules) as short projections into the unchanged
lumens of the tubules (Figure 7A). Cilia in LPK kidneys
were observed as long, often tangled, screwed or with
branches or knots (Figure 7B) and there were occasion-
ally multiple cilia per cell. In other cysts, epithelia had
no or very short cilia. The median and quartile length of
the cilia in the LPK distal tubule and collecting duct was
significantly longer than Lewis (LPK: 4.4 μm [3.3/5.6] vs.
Lewis: 1.7 μm [1.4/2.2], P < 0.0001), with the range of
values notably greater in the LPK kidney (Figure 7C).
Immunohistochemical labeling for acetylated α-tubulin
confirmed greater ciliary length in the LPK vs. Lewis
(Figure 8A and 8D). In the Lewis, double labeling for
Nek8 and γ-tubulin, or Nek8 and acetylated α-tubulin,
indicated that Nek8 was localised to a discrete region in
the proximal portion of the cilia (Figure 8E and F). In
the LPK, double labeling with Nek8 and γ-tubulin, or
Nek 8 and acetylated α-tubulin showed variable posi-
tioning of Nek8 in cilia, being either absent, present at
the base or distal region of the cilia, or showing punctatestaining along the length of cilia (Figure 8B and C). This
was confirmed in additional experiments with triple
labeling for Nek8 and both γ-tubulin and acetylated
α-tubulin (Figure 9).
Discussion
This study found a novel SNP mutation (R650C) located
within the Nek8 gene on rat Chr 10 is responsible for
the autosomal recessive cystic kidney disease phenotype
identified in the LPK rat [28]. The LPK rat can now be
classified as a rat model of NPHP9 [21], and will be in-
valuable for delineating the complex disease processes
associated with NPHP, including hypertension and car-
diac disease [42].
The LPK phenotype is similar to that described for the
jck mouse Nek8 model [7,43], which also have elongated
renal cilia and altered ciliary Nek8 expression [26,43,44].
Longer cilia have also been reported in other animal
models of cystic renal diseases. The collecting ducts of
the wpk rodent model for Meckel-Gruber syndrome
[45], and NPHP3 mice [46], all display longer cilia. An
increase in length variability has been described previ-
ously in the cpk mouse [47], a model of ADPKD. Our
data supports the hypothesis that ciliary Nek8 plays a
key role in normal communication between the cilia and
Figure 6 Phyre2 predicted 3D representation of Nek8 and location of known and R650C mutations. Panels illustrate the predicted tertiary
protein structure for the Nek8 protein, by homologous threading by Phrye2 [37] . Panel A illustrates the Nek8 serine/threonine region and panel
B illustrates the RCC1 domains. The colors indicate our annotated blade structures that make up the well-established propeller structure. Panels C
and D show the RCC1 domain in two perspectives, illustrating the spatial organisation of known mutations for NPHP9 in human, mouse (jck) and
R650C (illustrated by the red circles). Numbers indicate the standard designation of mutation within the protein. For example, Human A497P
indicates the alanine at position 497 has been mutated to proline. Figures highlight the peripheral location of the mutations, indicating the
probable requirement of all blades in protein interactions.
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such that its reduced expression or inadequate
localization results in the formation of cysts [7].
Whether an increase in cilia length is the effect of cysto-
genesis, or a primary defect in the assembly and main-
tenance of the cilium as a key pathogenic mechanism
remains a controversial issue, as elongation of the cilium
is also linked to injury [48-50].
The impact of an arginine (R) to cysteine (C) change
can potentially result in disulfide bridge formation, result-
ing in loss of rigidity in protein movements and conform-
ational changes. An example of the impact of an R to C
change can be found in the insulin receptor. The IRR252C
mutation results in an impairment of insulin binding, with
downstream effects of reduced insulin degradation and
insulin-induced receptor down-regulation [51].
In order to better interpret the functional consequences
of the R650C mutation in the LPK rats, we determined
that the position of the mutation occurred within a
repeated domain found in proteins with so-calledpropeller structures [36]. This RCC1 domain and the
serine/threonine kinase domain are both evolutionary
conserved features of the Nek8 protein [36]. The RCC1
and serine/threonine kinase domains could be clearly
identified in the predicted 3D structure that was modeled
from the amino acid sequence.
Manual comparison to the crystal structure of the
Golden hamster RCC1 protein [39] confirmed that the
motif in which the R650C mutation occurred is prominent
in protein-protein interactions. For example, the outer
regions of the blades of the reference RCC1 proteins form
the conformationally diverse loop region that interacts with
the GTPase Ras-related nuclear protein (Ran) [52]. An-
other example of an RCC1 domain-containing protein that
has a mutation within the G[RCQ]LG sequence is the pro-
tein Alsin, a guanine nucleotide exchange factor for Rab5
and Rac1. Mutations in this gene result in autosomal reces-
sive motor neuron disease [53]. Alsin, similar to Nek8, has
been predicted to form a 7 bladed propeller. The mutation
G540E in Alsin is similar to the H425Y and R650C in
Figure 7 Determination of cilia structure in the LPK. Scanning
electron micrographs of renal epithelial cells from Lewis control (A)
and LPK (B) kidney. The median length of primary cilia is greater in
the LPK and they show a greater range of cilia lengths (C). Scale
bars in panels A & B are indicative for that panel.
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itself within the conserved motif between the R650C and
H425Y mutation (G[R650C]L[G540E][H425Y]). Structural
analysis by Soares et. al. (2009) [53] predicts that this muta-
tion destabilizes the structure resulting in the observed
protein delocalization and cytotoxicity. This is also in ac-
cordance with Mollinari et. al (2003) [54] who illustrate themotif as a structural component that hinges the blades
together.
A recent study has shown that correct localization of
Nek8 to centrosomes and cilia requires both Nek8 catalytic
activity and the RCC1 domain [55]. The authors propose
that a region incorporating the G448V and H425Y muta-
tions, present within blade 3 of the RCC1 domain, is a
centrosome/cilia targeting sequence [55]. The authors
demonstrated that none of the known Nek8 mutations
identified in NPHP patients, nor that of the jck mouse, had
altered Nek8 kinase activity. They further propose that
autophosphorylation within the RCC1 domain caused a
conformational change that reveals a cilia/centrosome-tar-
geting site. Among the Nek8 mutations studied by Zalli
et al. (2011) [55] the ones of specific interest were those
that were homozygous (ie G448V, H425F). The interpret-
ation of these mutations as exposing a cilia/centrosome tar-
geting motif needs to be modified in light of the R650C
mutation reported in this paper. The H425Y mutation and
R650C mutations are predicted to be located between
strands C and D (blades 3 and 7) and both are located at or
near the conserved G[QRC]LG motif. These observations,
taken together with other structure function studies on
RCC1 like proteins, suggests that the seven bladed beta-
propeller structure as a whole is important, rather than in-
dividual component blades or part thereof. We propose
that the G[QRC]LG motif is an important component for
defining the integrity of the ‘axial’ region on which the pro-
peller structure is based.
Taking into account structural similarities of proteins
RCC1 domains (Alsin, RCC1 and TD-60 [54]) and the
mutations R650C, H425Y and G448V within Nek8’s RCC1
domain, we contend that interactions with different pro-
teins or conformational changes within the propeller
structure as a unit per se are therefore important in alter-
ing the function of Nek8. This model is similar to observa-
tions on the RCC1 protein coupled to the GTPase Ran,
where all blades of the RCC1 propeller are involved in
forming the RCC1-Ran complex [39,52]. Studies on a
related protein, Nek9 [56,57] directly defined phosphoryl-
ation activity associated with the serine/threonine kinase
activity and the control of this activity by the RCC1 do-
main. Furthermore, it has been demonstrated that the
Nek9 RCC1 domain was the domain capable of binding
Ran [57,58]. The role of this domain in Nek8 is thus in-
ferred to be a regulatory domain for the kinase.
It is of interest that the mouse and rat mutations in
Nek8/NPHP9 lead to a phenotypic presentation of polycys-
tic kidney disease that resembles human ARPKD, with an
early onset, enlarged cystic phenotype and widespread cyst
development [28,44]. In contrast, in human NPHP, the ma-
jority of mutations result in a juvenile onset form of dis-
ease, having kidneys that are reduced in size and cysts
arising at the corticomedullary border through loss of
Figure 8 Localisation of Nek8 in the cilia of Lewis and LPK. Immunohistochemical labeling for acetylated α-tubulin, γ-tubulin and Nek8 in
LPK (A, B, C) and Lewis (D, E, F) animals. Single labeling for acetylated α-tubulin (panels A and C) confirmed the abnormal length of cilia in the
LPK animals. Double labeling with Nek8 (red) and γ-tubulin (green, as a marker for the basal body) indicated that Nek8 was in close proximity to
the base of the cilia in the Lewis (E), but was located at variable positions along the cilia in the LPK (B). Double labeling with Nek8 (red) and
acetylated α-tubulin (green, panels C and F) confirmed the altered expression of Nek8 along the length of the cilia in the LPK (C). Arrows
highlight examples of cilia identified by either acetylated α-tubulin or γ-tubulin. Scale bars in each panel represent 5μm.
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NPHP, which arises from mutations in NPHP2/Inversin,
and presents with a comparable histopathology to that of
the rodent models. The known mutations in human Nek8/
NPHP9 were identified through screening of patients clin-
ically defined as NPHP, however it is indiscernible from
that study what the clinical phenotype of these patients
was [10].
Phenotypic difference is not unique in rodent models of
PKD, for as noted by Fischer et al (2004) [60], the mouse
pcy model of NPHP3 was initially proposed as model of
ADPKD [61] and the pck rat model, while presenting withFigure 9 Abnormal expression of Nek8 along the cilia in the LPK. Imm
and Nek8 in LPK animals. The use of both γ-tubulin (green, as a marker for
cilia) confirmed the altered expression of Nek8 (red) along the length of th
in panels A and B. Round circle indicates γ-tubulin while the dashed line h
each panel represent 5μm.an ADPKD phenotype, is due to a mutation in Pkhd1, the
rat orthologue of the human gene responsible for ARPKD
[62]. While the nature of the mutations may be respon-
sible for these phenotypic differences, it has recently been
shown that mutations in NPHP2/Inversin always result in
infantile NPHP with enlarged kidneys, regardless of the
mutation type [63]. Relevant to this study, Inversin and
Nek8 have a tightly coupled structural and functional rela-
tionship within the cilia [22,64] and future studies are war-
ranted to determine if the interactions between Nek8 and
Inversin explain the phenotypic similarities between these
forms of NPHP.unohistochemical triple labeling for acetylated α-tubulin, γ-tubulin
the basal body) and acetylated α-tubulin (green, as a marker for the
e cilia in the LPK. Two examples illustrating multiple cilia are presented
ighlights the cilia as identified using acetylated α-tubulin. Scale bars in
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The identification of the LPK mutation in the Nek8 gene is
consistent with many lines of evidence linking this gene to
NPHP. The location of the mutation in the RCC1 domain
and our demonstration of altered Nek8 localisation sup-
ports the hypothesis that ciliary Nek8 plays a key role in
normal communication between the cilia and the processes
of cellular differentiation and proliferation, such that its
dysfunction results in the formation of cysts. Our analysis
establishes the LPK rat model for studies aimed at defining
the key network systems linking regulation of the cell cycle
with cilia, basal bodies and centrosomes, and further, pro-
viding a pathological model for the study of cystic kidney
disease, and the development of potential intervention and
treatment strategies.
Methods
Animals
All animals were sourced from the Animal Resource
Centre, Murdoch, Western Australia, Australia. Experi-
ments were conducted in accordance with the National
Health and Medical Research Council Australian code of
practice for the care and use of animals for scientific
purposes and approved by the Murdoch University and
Macquarie University Animal Ethics Committees.
The lpk mutant arose as a spontaneous mutation from
the Lewis (LEW/SsNArc) strain at the Animal Resource
Centre, (Perth WA, Australia) [28]. Two strategies were
used to obtain DNA for linkage genetic analysis. LPK
males and Brown Norway (BN/ssArc) females were
crossed and first filial (F1) hybrids intercrossed to pro-
duce 152 (LPKxBN) second filial (F2) segregants, with a
segregation pattern of LPK:non LPK (42:110), as
reported previously [28]. LPK and Wistar Kyoto (WKY/
NArc) females were crossed and the F1 hybrids crossed
back to the LPK males to produce 139 (LPKxWKY) BC1
segregants with a segregation pattern of LPK:non LPK
(72:67) within the F2 generation, being consistent with
an autosomal recessive mutation.
Phenotype data
Prior to euthanasia animals were weighed, urine col-
lected and systolic blood pressure determined by tail-
cuff plesmography, using an average of 3 measurements
after the animals were acclimatized to the procedure
(NIBP controller, ADI Instruments, Castle Hill, NSW,
Australia). The animals were euthanized using CO2/O2.
Blood was collected by cardiac puncture and tissues
were dissected and weighed. Kidneys were then fixed in
4% formalin in 0.01M phosphate buffer (PB) for subse-
quent histology and the liver was collected and frozen at
-80˚C for genomic analysis. Blood was analysed for
serum urea and creatinine, total protein and albumin
using a Rx Daytona analyser (Randox Laboratories,Antrum, UK). Micro haematocrit tubes were used to de-
termine packed cell volume and urinary protein to cre-
atinine ratio was determined using a Cobas Mira
analyser (Roche Diagnostics, Schweiz, AG).
In order to determine the ratio of cyst area to total
kidney area, kidney sections were processed for histology
by paraffin embedding, sectioning (4μm) and staining
with haematoxylin and eosin (H&E). Images of kidney
were captured using a Nikon Dx40 Digital SLR and then
digitally enhanced to maximize contrast (Additional file
4: Figure S3). The area of cyst to cross sectional area of
the kidney (μm2) was determined using Image J [65].
Genotyping
DNA was extracted from the liver using the WizardW
Genomic DNA Purification Kit (Promega, Maddison,
WI, USA) following the manufacturer’s protocol. The
samples were assayed for DNA concentration and con-
tamination using a NanoDrop 1000 Spectrophotometer
(ThermoFisher Scientific, Scoresby, Vic, Australia). DNA
was stored at -80˚C and working samples diluted to
50ng/μl in MilliQ H2O and stored at -20˚C. Preliminary
polymerase chain reaction (PCR) studies of the BC1
using 2-4 simple sequence length polymorphism (SSLP)
markers per chromosome (obtained from [66]) mapped
the lpk locus to chromosome 10 between markers
D10Rat43 (23.42Mbp) and D10Rat26 (77.09Mbp). Using
primer sequences available from Rat Genome Database
(RGD) [32] additional polymorphic DNA markers (17 in
the BC1 and 12 in the F2, refer Additional file 5: Table
S2), synthesized by Geneworks (Adelaide, SA) were then
used to further genotype the animals by PCR. The defin-
ing markers obtained from the interval mapping from
the BC1 and F2 generation were used for comparative
analysis between the rat, mouse and human using the
Virtual Comparative Map [VCM, RGD [32]].
PCR was performed with Taq polymerase 0.055 U/μl
(Fisher Biotech, Australia) in 10 μl reaction volume con-
taining forward and reverse primers 0.5μM, dNTPs
0.25mM, MgCl 1.5mM. Cycling conditions consisted of
4 stages. Stage 1: TAQ activation 94˚C, 5 mins. Stage 2:
touchdown protocol, 12 cycles of 94˚C for 30s, anneal-
ing for 45s commencing at 54˚C with a 0.5˚C drop in
temperature per cycle, and elongation at 74˚C for 30s.
Stage 3: 32-40 cycles of denaturing at 94˚C for 30s,
annealing at 48˚C for 45s, and elongation at 74˚C for
30s. Stage 4: 1 cycle as per stage 3 with a 5 minute ex-
tension and sample hold at 14˚C. PCRs were performed
on an Applied Biosystems Veriti™ Thermal Cycler.
Genotyping of the animals was carried out on the
Protean II xi | XL cell (BioRad) using T= 8% [monomer]
and C= 5% [crosslinker] PAGE gels run at 70-80V for
18-22 hours. Gels were post stained with SYBRW Safe
(Invitrogen, Aust) for 30 minutes and photographed
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sition software (v. 15.06, Vilber Lourmat, Germany). The
lanes were scored as Homozygote [WKY (A) in the BC1
and BN (A) in the F2 generation & LPK (B)] or Hetero-
zygote (H) (Figure 1).
QTL analysis
Coinheritance of the phenotypic parameters with poly-
morphic DNA markers was analyzed by QTL analysis
using Map Manager QTX [31] and WinCart QTL [67].
The map in the present paper focused on chromosome
10 based on earlier work (unpublished). The QTL was
determined by cumulative interval mapping (CIM) with
forward and reverse regression using model 6 with a
window size of 0.5 cM and walk speed of 1 cM. The
threshold was determined using permutations, with per-
mutations set to 1000 and significance 0.05.
SNP identification
DNA was extracted from the liver of three 6-week old
male LPK animals and three 6-week old male Lewis gen-
etic controls, derived from the same inbred line from
which the mutation arose (LEW/SsNArc) but selected
without the mutation, using a DNeasy Blood & Tissue
Kit (QIAGEN, Vic, Australia) following the manufac-
turer’s protocol. DNA was checked for quality on a 2%
agarose gel and LPK and Lewis samples were respect-
ively pooled.
A Roche Nimblegen sequence capture array (Roche
NimbleGen Inc. Madison, WI, USA) was designed to en-
hance the region of interest and Illumina sequencing
reactions of the ~200 bp DNA regions were carried out
by the Australian Genome Research Facility Ltd (AGRF,
Gehrmann Laboratories, St Lucia, QLD, Australia) yield-
ing 100 bp single end sequence reads. Alignment of the
reads was performed using the open source short read
aligner Bowtie (release 0.12.5) [68] and limited to 2 mis-
matches. Homozygous and heterozygous SNPs were
identified using the freeware Package SHORE [69]. Sam-
ples were concurrently analyzed by AGRF QLD using
CASAVA Software (version 1.7, Illumina Inc. San Diego,
CA, USA) to identify SNPs. Both approaches yielded the
same result. Biological network analyses were drawn
from published literature on PKD and links to cilia and
cell division target genes of interest were refined further
using the web based programs Search Tool for the Re-
trieval of Interacting Genes/Proteins [70] Cytoscape
[71], Inner Medullary Collecting Duct Proteome Data-
base [72] and Murine Immortalized Cortical Collecting
Duct Cell (mpkCCD) Transcriptome Database [73].
Sequence read archive accession numbers
Ilumina raw sequence data for the Lewis (LEW/SsNArc)
wild type strains and LPK mutant were submitted to theNCBI Sequence Read Archive (SRA) under the submis-
sion numbers SRA056808 and SRA056807, respectively.
Direct sequencing of target SNP region
Amplification of the identified lpk SNP region within
Nek8 was carried out using standard PCR techniques
with the forward and reverse primers (nk-f3: 50 TCA
AGA TGG TGA TGG TGG 30) and (nk-r3: 50 TGA TGT
CAC CGT GTA AGG 30), respectively. Primers were
designed using Primer3 [74] to produce a 173 bp prod-
uct covering the homozygous SNP identified by direct
sequencing. Parental BN, WKY & LPK and selected BC1
progeny (animal numbers 85, 87, 90 and 92) were
assayed and product visualized on a 1.6% agarose gel.
The product was purified using the Promega WizardW
Gel and PCR cleanup system. Thirty ng of product, as
determined by spectrometer (Thermo Fisher Scientific,
Scoresby, Vic) was used as the template for sequencing
using the forward primer only (nk-f3) , with the BigDye
Terminator v3.1 Cycle Sequencing Kit (Applied Biosys-
tems, CA, USA) as per the manufacturer’s instructions.
The PCR sequencing reaction consisted of 96˚C for 2
mins, followed by 30 cycles of 96˚C for 10s, 48˚C for
10s and 60˚C for 10s. The product was then purified
using an EDTA/NaAc ethanol precipitation technique
and samples stored at -20˚C. Sequencing was performed
on a capillary sequencer (Applied Biosystems 3730xl
DNA Analyzer, CA, USA). The chromatograph calls
were aligned and visualised using the software Geneious
version 5.5 [75].
Protein structure prediction of the Nek8 protein
The Rattus norvegicus Nek8 protein (NP_ 001099274)
was aligned to the homologous proteins of Homo sapiens
(NP_835464), Mus musculus (NP_543125), Gallus gallus
(XP_415822), Danio rerio (NP_620766), Xenopus tropi-
calis (NP_001006906), Xenopus laeivis (NP_001090238)
Saccoglossus kowalevskii (XP_002730582). The alignment
was conducted using MAFFT version 6.814b [76] using
a Blosum62 scoring matrix with the following para-
meters: 1.53 for the Gap open penalty and 0.123 for the
offset value.
RCC1-like repeats for NP_001099274 (R. novegicus
Nek8) were analysed by the web based program REP
[77]. Secondary protein structure was predicted using
the Emboss tool Garnier [78], whilst the tertiary protein
structure prediction and 3D modeling were performed
using Phyre2 [37] and ESyPred [38].
Preliminary work was conducted based on an initial
VYxWG motif that early papers described as fingerprint-
ing RCC1 repeats [39]. This was modified to [VILC]xx
[WLFC]G, to account for variation within Nek8 and the
RCC1 protein. Sequences for the initial blade alignments
using MAFFT were determined using the RCC1 motif
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acids downstream. A final blade was selected, being an
intervening sequence between blades (non-canonical
blade 2). The 7 predicted blades were then aligned using
MAFFT against the known RCC1 blades of the Mesocri-
cetus auratus (Golden Hamster [UniProtKB: P23800])
for which a crystal structure is available [39].
Functional domains
Possible functional sites and domains were determined
within the Nek8 protein using the web based program
Eukaryotic Linear Motif Resource (ELM: [79]). Possible
functional motifs within domains were then refined
based on predicted 3-D structure of the Nek8 protein
and in particular the outer regions of the folded protein
because these were most likely to be involved in protein-
protein interactions.
Conserved G[X]LG motif within the blades of the
RCC1 domain
The G[X]LG motif was identified as a key feature of the
RCC1 domain of Nek8. In order to increase the specifi-
city of the search, the motif GX(5)GXF(4)G[QRC]LG
was used in the web based application Prosite [41]. The
proteins containing this sequence were then entered into
the web based programme KAAS [80] to examine pos-
sible pathway connections/ functionality associated with
the sequence.
Scanning electron microscopy
Tissue processing
Four Lewis (standard inbred LEW/CrlBR) and 4 LPK
animals aged 10-12 weeks of mixed sex were deeply
anaesthetised (sodium pentobarbitone 60 mg/kg i.p.) and
transcardially perfused at 110mmHg with heparinized
saline (0.2% heparin, Mayne Pharma Pty Ltd, Melbourne,
Vic, Australia and 0.9% w/v NaCl2), and then 2.5% (v/v)
glutaraldehyde solution (ProSciTech Pty Ltd, Brisbane,
QLD, Australia) in 0.1M PB, pH 7.4. Kidneys were dis-
sected, sectioned into coronal slices 1 mm thick, and
post-fixed for 24 hours in the same fixative solution.
Samples were sectioned into 3 mm x 1 mm wedges,
washed in 0.1M PB, post-fixed in 1% (v/v) osmium tet-
roxide solution, washed in 0.1M PB, dehydrated in
graded series of ethanol (30-100%) and critical point
dried in a EMITECH K850 Critical Point drier, with
CO2 as a transition fluid. Kidney fragments were
mounted on the aluminum stubs, covered previously
with carbon tabs and coated with gold using EMITECH
sputter coater K550.
Imaging and cilia measurement
Samples were viewed with JEOL JSM- 6480 LA Scan-
ning Electron Microscope (Jeol USA, Inc.) and filesstored as jpg. To determine cilia length images were
opened using Image J software [65] and cilia length mea-
sured using the Freehand tool after calibration of the
image scale. Cilia were selected from random fields of
distal and collecting tubules. For LPK, total number of
cilia measurements was 788 (from each animal average
n = 197 ± 6.78) and for Lewis, a total of 159 cilia were
measured (from each animal average n = 53.5 ± 30.35).
The differences in number of cilia measured from each
LPK and Lewis rat was due to cysts, which in the LPK
allowed ready access of cilia for SEM from broad fields
of cells, while in Lewis samples, cross sections of normal
tubules presented only small fields of view and therefore
limited numbers of cells with cilia available for assess-
ment. A D’Agostino-Pearson test was used to determine
normality of data and a two-tailed Mann–Whitney
T-test was used for comparison of cilia length between
Lewis and LPK. Results are presented as median and
quartiles (25th/ 75th percentile). All analyses were under-
taken using the statistical package Prism 5 for Mac
(Version 5.0d, GraphPad Software, La Jolla, USA).
Nek8 immunohistochemistry
Three 10-week old female LPK and three 10-week old
female Lewis rats (LEW/CrlBR) were deeply anaesthe-
tised (sodium pentobarbitone 60 mg/kg i.p.) and trans-
cardially perfused at 110mmHg with heparinised saline
followed by 4% formalin containing 0.01M PB (pH 7.4)
for 45 minutes. Kidneys were removed and post-fixed
for 24 hours in the same fixative at 4°C, then stored in
0.01M PB at 4°C until processed. Kidneys were sectioned
coronally, paraffin embedded and 10 μm sections cut
and mounted onto Superfrost Plus slides, then deparaffi-
nised with xylene and hydrated in a descending series of
graded ethanol solutions. Antigen retrieval was per-
formed with 10 mM citrate buffer pH 6 (Sigma Chem-
ical Co., USA). Buffer was heated to boiling, the samples
placed in solution and microwaved for 5 min at 720W
power and then allowed to cool to room temperature.
Sections were then incubated in blocking solution con-
taining tris phosphate buffered saline solution (TPBS-Tx;
10 mM tris base, 0.01 M PB, 0.9% w/v NaCl, 0.1% v/v
Triton X 100 and 0.1% w/v sodium azide, pH 7.4) with
10% v/v donkey serum (Sigma-Aldrich, USA) for 1 hour
at 20°C. Primary antibodies were diluted in the blocking
solution and samples incubated at 4°C overnight. Experi-
ments were initially performed as either single or double
labelled experiments using a polyclonal anti-Nek8 anti-
body (1:200 [81]), a mouse anti-acetylated α-tubulin
antibody (1:5000, T7451, clone 611B-1, Sigma-Aldrich,
USA) or mouse anti γ-tubulin (1:500, T5326, clone
GTU-88, Sigma-Aldrich, USA). After washing in PBS
(3 x 30 min), species-specific fluorescent-labelled sec-
ondary antibodies were used to detect primary antibody
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noresearch, USA] and donkey anti-mouse Dylight 488
[1:500, Jackson Immunoresearch]). Sections were again
washed (3 x 30 min) and coverslips mounted using
fluorescent mounting media (Dako, Denmark). Add-
itional experiments were performed in the LPK animals
with all three antibodies as a triple label, as γ-tubulin
and α-tubulin antibodies identified discrete structural
regions (basal body and ciliary shaft, respectively) and
could be distinguished by location, despite both being
identified by the same secondary anti-mouse Dylight 488
antibody.
The sections were imaged on a Leica TCS SP5 confocal
microscope (Leica Microsystems, Wetzlar, Germany),
equipped with an argon laser, with excitation and detec-
tion wavelengths set for Dylight 488 (excitation 488 de-
tection range 496 to 552 nm) and Cy3 (excitation 514
detection range 555 to 625 nm). For double labelled sec-
tions, images were collected using sequential acquisition
between stacks. Images were adjusted for brightness and
contrast only.Additional files
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